Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death

References

• Brooks BR, Miller RG, Swash M, et al. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Sci. 2000;1:293–299.
   PubMed Web of Science ®Google Scholar
• Brotman RG, Moreno-Escobar MC, Joseph J, et al. Amyotrophic lateral sclerosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; June 12, 2020.
   Google Scholar
• Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3(1):17085.
   PubMedGoogle Scholar
• Valko K, Ciesla L. Amyotrophic lateral sclerosis. Prog Med Chem. 2019;58:63–117.
   PubMedGoogle Scholar
• Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369(9578):2031–2041.
   PubMed Web of Science ®Google Scholar
• Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401–408.
   PubMed Web of Science ®Google Scholar
• Laferriere F, Polymenidou M. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med Wkly. 2015;145:w14054.
   PubMed Web of Science ®Google Scholar
• Alsultan AA, Waller R, Heath PR, et al. The genetics of amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis. 2016;6:49–64.
   PubMed Web of Science ®Google Scholar
• Fay MM, Anderson PJ, Ivanov P. ALS/FTD-associated C9ORF72 repeat RNA promotes phase transitions in vitro and in cells. Cell Rep. 2017;21(12):3573–3584.
   PubMed Web of Science ®Google Scholar
• Gopal PP, Nirschl JJ, Klinman E, et al. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc Natl Acad Sci U S A. 2017;114(12):E2466–E2475.
   PubMed Web of Science ®Google Scholar
• Johnson BS, Snead D, Lee JJ, et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284(30):20329–20339.
   PubMed Web of Science ®Google Scholar
• Patel A, Lee HO, Jawerth L, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162(5):1066–1077.
   PubMed Web of Science ®Google Scholar
• Carija A, Navarro S, De Groot NS, et al. Protein aggregation into insoluble deposits protects from oxidative stress. Redox Biol. 2017;12:699–711.
   PubMed Web of Science ®Google Scholar
• Gill C, Phelan JP, Hatzipetros T et al SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Sci Rep 2019;9(1):6724.
   PubMedGoogle Scholar
• Zhu C, Beck MV, Griffith JD, et al. Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2018;115(18):4661–4665.
   PubMed Web of Science ®Google Scholar
• Cozzolino M, Pesaresi MG, Amori I, et al. Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxid Redox Signal. 2009;11(7):1547–1558.
   PubMed Web of Science ®Google Scholar
• Kamelgarn M, Chen J, Kuang L, et al. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc Natl Acad Sci U S A. 2018;115(51):E11904–E11913.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, Mediani L, Alberti S, et al. ALS and FTD: where RNA metabolism meets protein quality control. Semin Cell Dev Biol. 2020;99:183–192.
   PubMed Web of Science ®Google Scholar
• Pasinelli P, Belford ME, Lennon N, et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43(1):19–30.
   PubMed Web of Science ®Google Scholar
• Woerner AC, Frottin F, Hornburg D, et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 2016a;351(6269):173–176. .
   PubMed Web of Science ®Google Scholar
• Soo KY, Sultana J, King AE, et al. ALS-associated mutant FUS inhibits macroautophagy which is restored by overexpression of Rab1. Cell Death Discov. 2015;1(1):15030.
   PubMedGoogle Scholar
• Stoica R, Paillusson S, Gomez-Suaga P, et al. ALS/FTD-associated FUS activates GSK-3beta to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. EMBO Rep. 2016;17(9):1326–1342. .
   PubMed Web of Science ®Google Scholar
• Veglianese P, Lo Coco D, Bao Cutrona M, et al. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS. Mol Cell Neurosci. 2006;31(2):218–231.
   PubMed Web of Science ®Google Scholar
• Guerrero EN, Mitra J, Wang H, et al. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum Mol Genet. 2019;28(15):2459–2476.
   PubMed Web of Science ®Google Scholar
• Wang H, Guo W, Mitra J, et al. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in amyotrophic lateral sclerosis. Nat Commun. 2018a;9(1):3683.
   PubMedGoogle Scholar
• Wang WY, Pan L, Su SC, et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci. 2013b;16(10):1383–1391.
   PubMed Web of Science ®Google Scholar
• Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544–558.
   PubMed Web of Science ®Google Scholar
• Conlon EG, Manley JL. RNA-binding proteins in neurodegeneration: mechanisms in aggregate. Genes Dev. 2017;31(15):1509–1528.
   PubMed Web of Science ®Google Scholar
• Kim G, Gautier O, Tassoni-Tsuchida E, et al. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108(5):822–842.
   Web of Science ®Google Scholar
• Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416–438.
   PubMed Web of Science ®Google Scholar
• Taylor JP, Brown RH Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197–206.
   PubMed Web of Science ®Google Scholar
• Shorter J, Taylor JP. Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly. Rare Dis. 2013;1(1):e25200.
   PubMedGoogle Scholar
• Maharana S, Wang J, Papadopoulos DK, et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science. 2018;360(6391):918–921. .
   PubMed Web of Science ®Google Scholar
• Dormann D, Rodde R, Edbauer D, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. Embo J. 2010;29(16):2841–2857. .
   PubMed Web of Science ®Google Scholar
• Hofweber M, Hutten S, Bourgeois B, et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 2018;173(3):706–719 e713. .
   PubMed Web of Science ®Google Scholar
• Yoshizawa T, Ali R, Jiou J, et al. Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites. Cell. 2018;173(3):693–705 e622. .
   PubMed Web of Science ®Google Scholar
• Ito D, Seki M, Tsunoda Y, et al. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol. 2011;69(1):152–162.
   PubMed Web of Science ®Google Scholar
• Chen X, Wu X, Wu H, et al. Phase separation at the synapse. Nat Neurosci. 2020;23(3):301–310.
   PubMed Web of Science ®Google Scholar
• Guillen-Boixet J, Kopach A, Holehouse AS, et al. RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation. Cell. 2020;181(2):346–361 e317. .
   PubMed Web of Science ®Google Scholar
• Hubstenberger A, Noble SL, Cameron C, et al. Translation repressors, an RNA helicase, and developmental cues control RNP phase transitions during early development. Dev Cell. 2013;27(2):161–173.
   PubMed Web of Science ®Google Scholar
• Takahara T, Maeda T. Transient sequestration of TORC1 into stress granules during heat stress. Mol Cell. 2012;47(2):242–252.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu SB, Wang MR, et al. Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat Cell Biol. 2018b;20(10):1145–1158.
   PubMed Web of Science ®Google Scholar
• Mollet S, Cougot N, Wilczynska A, et al. Translationally repressed mRNA transiently cycles through stress granules during stress. Mol Biol Cell. 2008;19(10):4469–4479.
   PubMed Web of Science ®Google Scholar
• Zhang J, Okabe K, Tani T, et al. Dynamic association-dissociation and harboring of endogenous mRNAs in stress granules. J Cell Sci. 2011;124(23):4087–4095.
   PubMed Web of Science ®Google Scholar
• Mahboubi H, Stochaj U. Cytoplasmic stress granules: dynamic modulators of cell signaling and disease. Biochim Biophys Acta Mol Basis Dis. 2017;1863(4):884–895.
   PubMed Web of Science ®Google Scholar
• Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20(11):649–666.
   PubMed Web of Science ®Google Scholar
• Bom APDA, Rangel LP, Costa DCF, et al. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils IMPLICATIONS FOR CANCER. J Biol Chem. 2012;287(33):28152–28162.
   PubMed Web of Science ®Google Scholar
• Wolozin B. Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener. 2012;7(1):56.
   PubMedGoogle Scholar
• Conlon EG, Lu L, Sharma A, et al. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife. 2016;5. DOI:10.7554/eLife.17820
   PubMed Web of Science ®Google Scholar
• Hayes LR, Duan L, Bowen K, et al. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. Elife. 2020;9. DOI:10.7554/eLife.51685
   Web of Science ®Google Scholar
• Lee YB, Chen HJ, Peres JN, et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5(5):1178–1186. .
   PubMed Web of Science ®Google Scholar
• Mori K, Weng SM, Arzberger T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339(6125):1335–1338. .
   PubMed Web of Science ®Google Scholar
• Zhang K, Donnelly CJ, Haeusler AR, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525(7567):56–61. .
   PubMed Web of Science ®Google Scholar
• Cruts M, Gijselinck I, Van Langenhove T, et al. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Trends Neurosci. 2013;36(8):450–459.
   PubMed Web of Science ®Google Scholar
• Prado LGR, Bicalho ICS, Magalhaes D, et al. C9ORF72 and the FTD-ALS spectrum: a systematic review of neuroimaging studies. Dement Neuropsychol. 2015;9(4):413–421.
   PubMedGoogle Scholar
• Chou CC, Zhang Y, Umoh ME, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci. 2018;21(2):228–239. .
   PubMed Web of Science ®Google Scholar
• Hoell JI, Larsson E, Runge S, et al. RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol. 2011;18(12):1428–1431.
   PubMed Web of Science ®Google Scholar
• Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18(7):437–451.
   PubMed Web of Science ®Google Scholar
• Prudencio M, Belzil VV, Batra R, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci. 2015;18(8):1175–1182. .
   PubMed Web of Science ®Google Scholar
• Sun S, Ling SC, Qiu J, et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat Commun. 2015;6(1):6171. .
   PubMedGoogle Scholar
• Umoh ME, Fournier C, Li Y, et al. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology. 2016;87(10):1024–1030.
   PubMed Web of Science ®Google Scholar
• Wang Q, Conlon EG, Manley JL, et al. Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains. Genome Res. 2020;30(12):1705–1715.
   PubMed Web of Science ®Google Scholar
• Conlon EG, Fagegaltier D, Agius P,,, et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife. 2018;7. 10.7554/eLife.37754
   PubMed Web of Science ®Google Scholar
• Reber S, Stettler J, Filosa G, et al. Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. Embo J. 2016;35(14):1504–1521. .
   PubMed Web of Science ®Google Scholar
• Gerbino V, Carri MT, Cozzolino M, et al. Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm. Neurobiol Dis. 2013;55:120–128.
   PubMed Web of Science ®Google Scholar
• Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349(6248):650–625.
   Web of Science ®Google Scholar
• Tian B, Manley JL. Alternative polyadenylation of mRNA precursors. Nat Rev Mol Cell Biol. 2017;18(1):18–30.
   PubMed Web of Science ®Google Scholar
• Li WC, You B, Hoque M, et al. Systematic profiling of poly(A) plus transcripts modulated by core 3 ‘ end processing and splicing factors reveals regulatory rules of alternative cleavage and polyadenylation. PLoS Genet. 2015;11(4):e1005166.
   Web of Science ®Google Scholar
• Nazim M, Masuda A, Rahman MA, et al. Competitive regulation of alternative splicing and alternative polyadenylation by hnRNP H and CstF64 determines acetylcholinesterase isoforms. Nucleic Acids Res. 2017;45(3):1455–1468.
   PubMed Web of Science ®Google Scholar
• Masuda A, Takeda J, Okuno T, et al. Position-specific binding of FUS to nascent RNA regulates mRNA length. Genes Dev. 2015;29(10):1045–1057.
   PubMed Web of Science ®Google Scholar
• Rot G, Wang Z, Huppertz I, et al. High-resolution RNA maps suggest common principles of splicing and polyadenylation regulation by TDP-43. Cell Rep. 2017;19(5):1056–1067.
   PubMed Web of Science ®Google Scholar
• Tian B, Manley JL. Alternative cleavage and polyadenylation: the long and short of it. Trends Biochem Sci. 2013;38(6):312–320.
   PubMed Web of Science ®Google Scholar
• Tank EM, Figueroa-Romero C, Hinder LM, et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat Commun. 2018;9(1):2845.
   PubMedGoogle Scholar
• Zhou Y, Liu S, Liu G, et al. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9(10):e1003895.
   PubMed Web of Science ®Google Scholar
• Avendano-Vazquez SE, Dhir A, Bembich S, et al. Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev. 2012;26(15):1679–1684.
   PubMed Web of Science ®Google Scholar
• Mitchell JC, McGoldrick P, Vance C, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125(2):273–288.
   PubMed Web of Science ®Google Scholar
• Wils H, Kleinberger G, Janssens J, et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2010;107(8):3858–3863.
   PubMed Web of Science ®Google Scholar
• Chang YF, Imam JS, Wilkinson MF. The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem. 2007;76(1):51–74.
   PubMed Web of Science ®Google Scholar
• Ortega JA, Daley EL, Kour S, et al. Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron. 2020;106(1):90–107 e113.
   PubMed Web of Science ®Google Scholar
• Sun Y, Eshov A, Zhou J, et al. C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression. Nat Commun. 2020;11(1):3354.
   PubMed Web of Science ®Google Scholar
• Xu W, Bao P, Jiang X, et al. Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity. Brain. 2019;142(5):1349–1364.
   PubMedGoogle Scholar
• Barmada SJ, Ju S, Arjun A, et al. Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc Natl Acad Sci U S A. 2015;112(25):7821–7826.
   PubMed Web of Science ®Google Scholar
• Isken O, Kim YK, Hosoda N, et al. Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. Cell. 2008;133(2):314–327.
   PubMed Web of Science ®Google Scholar
• Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933.
   PubMed Web of Science ®Google Scholar
• Deng J, Yang M, Chen Y, et al. FUS interacts with HSP60 to promote mitochondrial damage. PLoS Genet. 2015;11(9):e1005357.
   PubMed Web of Science ®Google Scholar
• Onesto E, Colombrita C, Gumina V, et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol Commun. 2016;4(1):47.
   PubMedGoogle Scholar
• Deng J, Wang P, Chen X, et al. FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models. Proc Natl Acad Sci U S A. 2018;115(41):E9678–E9686.
   PubMed Web of Science ®Google Scholar
• Wang W, Li L, Lin WL, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013a;22(23):4706–4719.
   PubMed Web of Science ®Google Scholar
• Nakaya T, Maragkakis M. Amyotrophic lateral sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity. Sci Rep. 2018;8(1):15575.
   PubMedGoogle Scholar
• Tsai Y-L, Coady TH, Lu L, et al. ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes Dev. 2020;34(11–12):785–805.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang L, Lu J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22(8):869–878.
   PubMed Web of Science ®Google Scholar
• Wang P, Deng J, Dong J, et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15(5):e1007947.
   PubMed Web of Science ®Google Scholar
• Shpilka T, Haynes CM. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat Rev Mol Cell Biol. 2018;19(2):109–120.
   PubMed Web of Science ®Google Scholar
• Martinez BA, Petersen DA, Gaeta AL, et al. Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. elegans models of parkinson’s disease. J Neurosci. 2017;37(46):11085–11100.
   PubMed Web of Science ®Google Scholar
• Rizzuto R, Pinton P, Carrington W, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science. 1998;280(5370):1763–1766.
   PubMed Web of Science ®Google Scholar
• Kornmann B. The molecular hug between the ER and the mitochondria. Curr Opin Cell Biol. 2013;25(4):443–448.
   PubMed Web of Science ®Google Scholar
• Rowland AA, Voeltz GK. Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol. 2012;13(10):607–625.
   PubMed Web of Science ®Google Scholar
• Saotome M, Safiulina D, Szabadkai G, et al. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the miro GTPase. Proc Natl Acad Sci U S A. 2008;105(52):20728–20733.
   PubMed Web of Science ®Google Scholar
• Stoica R, De Vos KJ, Paillusson S, et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat Commun. 2014;5(1):3996. .
   PubMedGoogle Scholar
• Zhang YJ, Gendron TF, Grima JC, et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat Neurosci. 2016;19(5):668–677.
   PubMed Web of Science ®Google Scholar
• Bischoff FR, Klebe C, Kretschmer J, et al. RanGAP1 induces GTPase activity of nuclear ras-related ran. Proc Natl Acad Sci U S A. 1994;91(7):2587–2591.
   PubMed Web of Science ®Google Scholar
• Cole CN, Hammell CM. Nucleocytoplasmic transport: driving and directing transport. Curr Biol. 1998;8(11):R368–372.
   PubMed Web of Science ®Google Scholar
• Kendirgi F, Barry DM, Griffis ER, et al. An essential role for hGle1 nucleocytoplasmic shuttling in mRNA export. J Cell Biol. 2003;160(7):1029–1040.
   PubMed Web of Science ®Google Scholar
• Kendirgi F, Rexer DJ, Alcázar-Román AR, et al. Interaction between the shuttling mRNA export factor Gle1 and the nucleoporin hCG1: a conserved mechanism in the export of Hsp70 mRNA. Mol Biol Cell. 2005;16(9):4304–4315.
   PubMed Web of Science ®Google Scholar
• Kaneb HM, Folkmann AW, Belzil VV, et al. Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis. Hum Mol Genet. 2015;24(5):1363–1373. .
   PubMed Web of Science ®Google Scholar
• Nousiainen HO, Kestila M, Pakkasjarvi N, et al. Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease. Nat Genet. 2008;40(2):155–157.
   PubMed Web of Science ®Google Scholar
• Herva R, Conradi NG, Kalimo H, et al. A syndrome of multiple congenital contractures: neuropathological analysis on five fetal cases. Am J Med Genet. 1988;29(1):67–76.
   PubMed Web of Science ®Google Scholar
• Vuopala K, Ignatius J, Herva R. Lethal arthrogryposis with anterior horn cell disease. Hum Pathol. 1995;26(1):12–19.
   PubMed Web of Science ®Google Scholar
• Cho KI, Yoon D, Qiu S, et al. Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes. Dis Model Mech. 2017;10(5):559–579.
   PubMed Web of Science ®Google Scholar
• Hansen M, Rubinsztein DC, Walker DW. Autophagy as a promoter of longevity: insights from model organisms. Nat Rev Mol Cell Biol. 2018;19(9):579–593.
   PubMed Web of Science ®Google Scholar
• Cirulli ET, Lasseigne BN, Petrovski S, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436–1441.
   PubMed Web of Science ®Google Scholar
• Fecto F, Yan J, Vemula SP, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(11):1440–1446.
   PubMedGoogle Scholar
• Freischmidt A, Wieland T, Richter B, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631–636. .
   PubMed Web of Science ®Google Scholar
• Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223–226.
   PubMed Web of Science ®Google Scholar
• Bansal M, Moharir SC, Swarup G. Autophagy receptor optineurin promotes autophagosome formation by potentiating LC3-II production and phagophore maturation. Commun Integr Biol. 2018;11(2):1–4.
   PubMedGoogle Scholar
• Oakes JA, Davies MC, Collins MO. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain. 2017;10(1):5.
   PubMed Web of Science ®Google Scholar
• Richter B, Sliter DA, Herhaus L, et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A. 2016;113(15):4039–4044.
   PubMed Web of Science ®Google Scholar
• Deng Z, Lim J, Wang Q, et al. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. Autophagy. 2019;16(5):917–931.
   Google Scholar
• Wong YC, Holzbaur ELF . Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci U S A. 2014;111(42): E4439–E4448.
   Google Scholar
• De Majo M, Topp SD, Smith BN, et al. ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol Aging. 2018;71:266 e261–266 e210.
   Web of Science ®Google Scholar
• Barmada SJ, Serio A, Arjun A, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol. 2014;10(8):677–685.
   PubMed Web of Science ®Google Scholar
• Xia Q, Wang H, Hao Z, et al. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. Embo J. 2016;35(2):121–142. .
   PubMed Web of Science ®Google Scholar
• Ling SC, Dastidar SG, Tokunaga S, et al. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. Elife. 2019;8. DOI:10.7554/eLife.40811.
   Web of Science ®Google Scholar
• Chitiprolu M, Jagow C, Tremblay V, et al. A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy. Nat Commun. 2018;9(1):2794. .
   PubMed Web of Science ®Google Scholar
• Sullivan PM, Zhou X, Robins AM, et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol Commun. 2016a;4(1):51.
   PubMed Web of Science ®Google Scholar
• Ash PE, Bieniek KF, Gendron TF, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77(4):639–646.
   PubMed Web of Science ®Google Scholar
• Boivin M, Pfister V, Gaucherot A, et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. Embo J. 2020;39(4). DOI:10.15252/embj.2018100574
   PubMed Web of Science ®Google Scholar
• Sellier C, Campanari ML, Julie Corbier C, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. Embo J. 2016;35(12):1276–1297.
   PubMed Web of Science ®Google Scholar
• Yang M, Liang C, Swaminathan K, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv. 2016;2(9):e1601167.
   PubMed Web of Science ®Google Scholar
• Sea K, Sohn SH, Durazo A, et al. Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase. J Biol Chem. 2015;290(4):2405–2418
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhou B, Lin MY, et al. Endolysosomal deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS mice. Neuron. 2015;87(2):355–370.
   PubMed Web of Science ®Google Scholar
• Richard P, Feng S, Tsai YL, et al. SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation. Autophagy. 2020:1–18. 10.1080/15548627.2020.1796292
   PubMed Web of Science ®Google Scholar
• Richard P, Feng S, Manley JL. A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage. Genes Dev. 2013;27(20):2227–2232.
   PubMed Web of Science ®Google Scholar
• Skourti-Stathaki K, Proudfoot NJ, Gromak N. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol Cell. 2011;42(6):794–805.
   PubMed Web of Science ®Google Scholar
• Brambati A, Colosio A, Zardoni L, et al. Replication and transcription on a collision course: eukaryotic regulation mechanisms and implications for DNA stability. Front Genet. 2015;6:166.
   PubMed Web of Science ®Google Scholar
• Madabhushi R, Pan L, Tsai LH. DNA damage and its links to neurodegeneration. Neuron. 2014;83(2):266–282.
   PubMed Web of Science ®Google Scholar
• Konopka A, Atkin JD. The emerging role of DNA damage in the pathogenesis of the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Int J Mol Sci. 2018;19(10):3137.
   Web of Science ®Google Scholar
• Farg MA, Konopka A, Soo KY, et al. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum Mol Genet. 2017;26(15):2882–2896.
   PubMed Web of Science ®Google Scholar
• Qiu H, Lee S, Shang Y, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest. 2014;124(3):981–999.
   PubMed Web of Science ®Google Scholar
• Nihei Y, Mori K, Werner G, et al. Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3. Acta Neuropathol. 2020;139(1):99–118. .
   PubMed Web of Science ®Google Scholar
• Wang H, Hegde ML. New mechanisms of DNA repair defects in fused in sarcoma-associated neurodegeneration: stage set for DNA repair-based therapeutics? J Exp Neurosci. 2019;13:1179069519856358.
   Web of Science ®Google Scholar
• Rulten SL, Rotheray A, Green RL, et al. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage. Nucleic Acids Res. 2014;42(1):307–314.
   PubMed Web of Science ®Google Scholar
• Naumann M, Pal A, Goswami A, et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun. 2018;9(1):335. .
   PubMedGoogle Scholar
• Singatulina AS, Hamon L, Sukhanova MV, et al. PARP-1 activation directs FUS to DNA damage sites to form PARG-reversible compartments enriched in damaged DNA. Cell Rep. 2019;27(6):1809–1821 e1805.
   PubMed Web of Science ®Google Scholar
• Hock EM, Maniecka Z, Hruska-Plochan M, et al. Hypertonic stress causes cytoplasmic translocation of neuronal, but not astrocytic, FUS due to impaired transportin function. Cell Rep. 2018;24(4):987–1000 e1007.
   PubMed Web of Science ®Google Scholar
• Mitra J, Guerrero EN, Hegde PM, et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci U S A. 2019;116(10):4696–4705.
   PubMed Web of Science ®Google Scholar
• Freibaum BD, Taylor JP. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol Neurosci. 2017;10:35.
   PubMed Web of Science ®Google Scholar
• Andrade NS, Ramic M, Esanov R, et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol Neurodegener. 2020;15(1):13.
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez R, Lu Y, Gendron TF, et al. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92(2):383–391.
   PubMed Web of Science ®Google Scholar
• Freibaum BD, Lu Y, Lopez-Gonzalez R, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525(7567):129–133.
   PubMed Web of Science ®Google Scholar
• Takei K, Watanabe K, Yuki S, et al. Edaravone and its clinical development for a amyotrophic lateral sclerosis. Amyotroph Lat Scl Fr. 2017;18:5–10.
   PubMed Web of Science ®Google Scholar
• Mandrioli J, D’Amico R, Zucchi E, et al. Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Medicine (Baltimore). 2018;97(24):e11119.
   PubMed Web of Science ®Google Scholar
• Ly CV, Miller TM. Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis. Curr Opin Neurol. 2018;31(5):648–654.
   PubMed Web of Science ®Google Scholar
• Wheeler RJ, Lee HO, Poser I, et al. Small molecules for modulating protein driven liquid-liquid phase separa- 1345 tion in treating neurodegenerative disease. bioRxiv. 2019;721001. DOI:10.1101/721001.
   Google Scholar